Hepatitis B vaccine
Hepatitis B universal vaccination: learning from the French experience
Sunday 19 December 2004
par
This update has been written for the numerous prescribers and health professionals who are logically disturbed by a growing discrepancy between the recommendation they are receiving of protecting public heath by hepatitis B vaccination and an accumulation of alarming data on the hazards of this prophylaxis. Focused on a recent case/controls investigation which showed a 3-fold increase in the relative risk of multiple sclerosis after hepatitis B vaccine, this review was made upon systematic referencing from published or public data.
Marc Girard
This author's articles
- Vaccination des bébés : incompétence (Rivasi) contre mauvaise foi (Buzyn)
- Les perles du dixième anniversaire
- LA vérité sur les vaccins selon "Enquête de santé" (12/11/19)
- Écologie pour les nuls : suite et pas fin
- Médicaments dangereux, médicalisation, contraception : une interview dans l’émission "Bob vous dit toute la vérité"
- [...]
Keywords
-
Benefit/risk
- Vaccination contre l’hépatite B : essai de bilan chiffré
- Vaccin contre l’hépatite B : l’urgence d’une ré-évaluation
- Failure in drug safety assessment: a worrying issue far beyond manufacturer’s potential conflicts of interest
- Evaluation des statines
- Hepatitis B universal vaccination: learning from the French experience
- Evidence-based medicine (EBM)
- Hepatitis B
- Vaccine
Home page |
Contact |
Site Map |
Sign In |
Statistics |
visits: 1206764
en
Documents in English
Vaccines
?
Site created with SPIP 2.1.26 + AHUNTSIC
603 visitors now